BioRender-Icon

Cardiomyocyte (eccentric hypertrophy)

Cardiomyocyte (eccentric hypertrophy) - Editable icon of an elongated rectangular eccentric hypertrophic cardiomyocyte with banded sarcomere striations and one nucleus
[{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a1603a3b1a711/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a1603a3b1a711/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a1635ddb1a70f/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a1635ddb1a70f/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16226eb1a70e/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16226eb1a70e/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16f876b1a70d/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16f876b1a70d/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a165a57b1a70c/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a165a57b1a70c/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a162709b1a70b/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a162709b1a70b/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16b501b1a70a/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16b501b1a70a/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a162b12b1a709/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a162b12b1a709/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a165715b1a708/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a165715b1a708/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a166d94b1a707/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a166d94b1a707/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a164ff8b1a706/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a164ff8b1a706/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a1662c6b1a705/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a1662c6b1a705/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16ba2eb1a704/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16ba2eb1a704/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16b7b4b1a703/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16b7b4b1a703/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a167003b1a702/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a167003b1a702/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a160fd0b1a701/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a160fd0b1a701/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a168a80b1a700/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a168a80b1a700/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16ab2eb1a6ff/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16ab2eb1a6ff/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16577eb1a6fe/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16577eb1a6fe/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16f7d4b1a6fd/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16f7d4b1a6fd/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16f032b1a6fc/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16f032b1a6fc/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a166886b1a6fb/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a166886b1a6fb/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a1621b8b1a6fa/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a1621b8b1a6fa/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a167dd2b1a6f9/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a167dd2b1a6f9/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a169bbbb1a6f8/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a169bbbb1a6f8/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16f020b1a6f7/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16f020b1a6f7/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16775fb1a6f6/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16775fb1a6f6/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16cb49b1a6f5/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16cb49b1a6f5/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16aa24b1a6f4/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16aa24b1a6f4/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a163d6ab1a6f3/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a163d6ab1a6f3/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16efccb1a6f2/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16efccb1a6f2/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a1658eab1a6f1/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a1658eab1a6f1/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16c9beb1a6f0/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16c9beb1a6f0/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16e751b1a6ef/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16e751b1a6ef/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a167d6fb1a6ee/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a167d6fb1a6ee/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a1635d3b1a6ed/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a1635d3b1a6ed/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a167b64b1a6ec/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a167b64b1a6ec/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a160d95b1a6eb/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a160d95b1a6eb/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a168507b1a6ea/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a168507b1a6ea/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a161a98b1a6e9/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a161a98b1a6e9/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a167b22b1a6e8/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a167b22b1a6e8/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a1639e6b1a6e7/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a1639e6b1a6e7/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a164995b1a6e6/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a164995b1a6e6/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16cb08b1a6e5/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16cb08b1a6e5/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16a883b1a6e4/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16a883b1a6e4/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a166552b1a6e3/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a166552b1a6e3/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a168e99b1a6e2/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a168e99b1a6e2/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16d800b1a6e1/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16d800b1a6e1/652957d932b65c295b1be583.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/654916e18e0a16ef55b1a6e0/652957d932b65c295b1be583.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/654916e18e0a16ef55b1a6e0/652957d932b65c295b1be583.png"}]
Dieses Icon verwenden – Kostenlos
Für die Registrierung ist keine Kreditkarte erforderlich.

Dieses Icon ist in BioRender vollständig bearbeitbar

  • Fügen Sie Text, Formen und weitere Icons hinzu
  • Durchsuchen Sie über 50.000 wissenschaftlich korrekte Icons
  • Jedes Icon, jede Linie und jedes Label lässt sich umfärben und neu anordnen
  • Exportieren oder teilen für jeden Anwendungszweck
Scientist Avatars

Schließen Sie sich über 4 Millionen Wissenschaftlern an, die bereits publikationsreife Abbildungen erstellen

Vom Icon zur fertigen Abbildung – in wenigen Minuten

  • Suche aus über 50.000 wissenschaftlich korrekten, von Experten begutachteten Icons
  • Anpassen mit Beschriftungen, Formen und zusätzlichen Icons – alles ist vollständig bearbeitbar
  • Exportieren oder teilen Sie Ihre Abbildungen mit Mitarbeitern
    ‍
page dashboard

Nicht ganz das richtige Icon? Entdecken Sie mehr.

Durchsuchen Sie über 50.000 Icons aus mehr als 30 lebenswissenschaftlichen Fachbereichen.

search icon
arrow-right
Schlagwörter
cardiomyocyte,hypertrophy,hypertrophic,eccentric hypertrophy,dilated cardiomyopathy,DCM,pathological hypertrophy,valvular heart disease,heart damage,heart failure,heart remodeling,cardiac stress,hypertension,pressure overload,volume overload,blood pressure,myocardial infarction,pathology,heart disease,cardiac function,illness,heart,cardiac,cardio,smooth muscle,cardiac muscle,cardiac muscle cell,heart muscle,cardiac tissue,myocardium,involuntary,striated,intercalated disc,sarcomere,actin,myosin,troponin,t-tubule,myofibril,myofilament,cytoplasm,nucleus,cell membrane,contract,contraction,contractile,cardiomyopathy,heartbeat,heart contraction,heart rhythm,cardiac cycle,functional syncytium,action potential,excitation-contraction coupling,rectangular,healthy,isolated,lab research,in vitro,mammalian,adult,human,rodent,mouse,rat,cardiovascular system,cardiovascular,circulatory system,cardiovascular physiology,cardiology,regenerative medicine,cultured cardiomyocyte,cultured,mononucleated,cardiomyocyte
Mehr anzeigen

Versuchen Sie es mit einem Synonym oder registrieren Sie sich, um ein Icon über die App anzufordern.

Bildtypen

Cardiomyocyte (eccentric hypertrophy) icon JPEG

Cardiomyocyte (eccentric hypertrophy) icon PNG

Cardiomyocyte (eccentric hypertrophy) icon SVG

Cardiomyocyte (eccentric hypertrophy) icon GIF

Häufig gestellte Fragen zu BioRender-Icons

How are scientists using the Cardiomyocyte (eccentric hypertrophy) icon in their work?

BioRender users often use the Cardiomyocyte (eccentric hypertrophy) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

Kann ich dieses Icon in einer BioRender-Abbildung oder wissenschaftlichen Illustration verwenden?

Yes, the Cardiomyocyte (eccentric hypertrophy) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Cardiomyocyte (eccentric hypertrophy) icon customizable in BioRender?

Most icons in BioRender, including the Cardiomyocyte (eccentric hypertrophy) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Cardiomyocyte (eccentric hypertrophy) icon for publication or presentations?

Yes, figures containing the Cardiomyocyte (eccentric hypertrophy) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Cardiomyocyte (eccentric hypertrophy) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Cardiomyocyte (eccentric hypertrophy) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

Was ist BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Cardiomyocyte (eccentric hypertrophy) icon along with our library of more than 30,000 life science icons.

Dieses Icon in BioRender verwenden

Erstellen Sie noch heute professionelle wissenschaftliche Abbildungen
antibody elements3D Phospholipid illustration

Suchen Sie nach wissenschaftlichen Inhalten?

Durchsuchen Sie über 50.000 Icons und Vorlagen, die von Fachkollegen geprüft, einfach zu verwenden und kostenlos sind.

Finden Sie jetzt das Passende
x icon